Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.verified

SNPHF

Price:

$11.89

Market Cap:

$644.81B

Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that is in Phase III clinical trial. In addition, the company provides DE-114A to treat allergic conjunctivitis; DE-076C for the treatment of vernal keratoconjunctivitis; and DE-109, which is in Phase III clinical trial to treat uveitis. Further, it offe...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2010-06-09

Stock Exchange

PNK

Ticker

SNPHF

The Enterprise Value as of November 2024 (TTM) for Santen Pharmaceutical Co., Ltd. (SNPHF) is 555.07B

According to Santen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 555.07B. This represents a change of 19.16% compared to the average of 465.81B of the last 4 quarters.

Santen Pharmaceutical Co., Ltd. (SNPHF) Historical Enterprise Value (quarterly & annually)

How has SNPHF Enterprise Value performed in the past?

The mean historical Enterprise Value of Santen Pharmaceutical Co., Ltd. over the last ten years is 841.63B. The current 555.07B Enterprise Value has changed 6.50% with respect to the historical average. Over the past ten years (40 quarters), SNPHF's Enterprise Value was at its highest in in the March 2015 quarter at 3.45T. The Enterprise Value was at its lowest in in the September 2022 quarter at 346.66B.

Quarterly (TTM)
Annual

Average

841.63B

Median

587.92B

Minimum

424.13B

Maximum

3.44T

Santen Pharmaceutical Co., Ltd. (SNPHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Santen Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.00%

Maximum Annual Enterprise Value = 3.44T

Minimum Annual Increase = -82.30%

Minimum Annual Enterprise Value = 424.13B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024466.34B9.95%
2023424.13B-16.55%
2022508.23B-10.24%
2021566.19B-12.94%
2020650.32B6.17%
2019612.53B-2.33%
2018627.13B23.59%
2017507.43B-16.77%
2016609.64B-82.30%
20153.44T1.00%

Santen Pharmaceutical Co., Ltd. (SNPHF) Average Enterprise Value

How has SNPHF Enterprise Value performed in the past?

The current Enterprise Value of Santen Pharmaceutical Co., Ltd. (SNPHF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

466.23B

5-year avg

523.04B

10-year avg

841.63B

Santen Pharmaceutical Co., Ltd. (SNPHF) Enterprise Value vs. Peers

How is SNPHF’s Enterprise Value compared to its peers?

Santen Pharmaceutical Co., Ltd.’s Enterprise Value is less than Ono Pharmaceutical Co., Ltd. (935.34B), greater than GSK plc (69.84B), greater than Grifols, S.A. (14.96B), greater than Pfizer Inc. (225.71B),

CompanyEnterprise ValueMarket cap
935.34B$6.03B
69.84B$72.40B
14.96B$7.00B
225.71B$157.31B

Build a custom stock screener for Santen Pharmaceutical Co., Ltd. (SNPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santen Pharmaceutical Co., Ltd. (SNPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Santen Pharmaceutical Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Santen Pharmaceutical Co., Ltd. (SNPHF)?

What is the 3-year average Enterprise Value for Santen Pharmaceutical Co., Ltd. (SNPHF)?

What is the 5-year average Enterprise Value for Santen Pharmaceutical Co., Ltd. (SNPHF)?

How does the current Enterprise Value for Santen Pharmaceutical Co., Ltd. (SNPHF) compare to its historical average?